[144] BorgWarner Inc. SEC Filing

Rhea-AI Filing Summary

BorgWarner filed a Form 144 reporting a proposed sale of 2,500 common shares to be executed through Charles Schwab on 08/12/2025 with an aggregate market value of $100,025, to be listed on the NYSE. The 2,500 shares equal approximately 0.001155% of the issuer's 216,392,876 shares outstanding, indicating the sale is immaterial to the company’s overall capitalization. The shares were acquired as equity compensation: 1,380 from a restricted stock lapse on 02/28/2020 and 1,120 from a performance stock lapse on 02/05/2025, which together match the 2,500 shares proposed for sale. The filing also discloses two prior dispositions in the past three months totaling 10,000 shares for aggregate proceeds of $354,800. The signer represents no known undisclosed material adverse information.

Insights

Securities Analyst

Insider intends to sell 2,500 BWA shares; size is negligible relative to outstanding shares, so limited market impact.

The filing shows a proposed sale of 2,500 shares valued at $100,025 via Charles Schwab on 08/12/2025 against about 216.4 million shares outstanding, representing roughly 0.001155% of the float. The shares originated from equity compensation (restricted stock and performance stock lapses) and thus reflect routine insider liquidity rather than a transaction funded by market purchases. Recent reported dispositions total 10,000 shares in the last three months for $354,800 in proceeds. Given the small share counts relative to outstanding shares, the economic and market impact appears immaterial.

Corporate Governance Expert

Form 144 disclosure aligns with Rule 144 requirements; filer attests no undisclosed material adverse information.

The document documents the source of the shares as equity compensation and lists prior sales in the three-month lookback period, fulfilling standard disclosure expectations under Rule 144. The filing includes the statutory representation that the signer does not possess any undisclosed material adverse information. The filing does not provide a declared trading plan adoption date within the content provided, so no affirmative indication of a Rule 10b5-1 plan is present in this text.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2500	100025.00	216392876	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2020	Restricted Stock Lapse	BORGWARNER INC			1380	02/28/2020	Equity Compensation
Common	02/05/2025	Performance Stock Lapse	BORGWARNER INC			1120	02/05/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Isabelle McKenzie 3850 HAMLIN RD. AUBURN HILLS MI 48326	BORGWARNER INC	05/16/2025	5000	166250.00
Isabelle McKenzie 3850 HAMLIN RD. AUBURN HILLS MI 48326	BORGWARNER INC	08/04/2025	5000	188550.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BorgWarner (BWA) Form 144 report?

The filing reports a proposed sale of 2,500 common shares via Charles Schwab on 08/12/2025 with an aggregate market value of $100,025 on the NYSE.

Who is listed as the seller in the recent Form 144 disclosures for BWA?

The past three-month dispositions list Isabelle McKenzie at the provided address as the seller for those sales. The filing content does not explicitly populate a separate 'Name of Person for Whose Account' field in the excerpt provided.

How were the 2,500 shares to be sold acquired?

The shares were acquired as equity compensation: 1,380 via a restricted stock lapse on 02/28/2020 and 1,120 via a performance stock lapse on 02/05/2025.

What insider sales occurred in the past three months according to the filing?

Two dispositions are reported: 5,000 shares sold on 05/16/2025 for $166,250 and 5,000 shares sold on 08/04/2025 for $188,550, totaling 10,000 shares and $354,800 in proceeds.

What percentage of outstanding shares does the proposed 2,500-share sale represent?

The proposed sale of 2,500 shares is approximately 0.001155% of the reported 216,392,876 shares outstanding.

Does the filing indicate any undisclosed material adverse information?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed; the document contains that attestation text.